<?xml version='1.0' encoding='utf-8'?>
<document id="19962282"><sentence text="Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods." /><sentence text="The purpose of this study was to integrate knowledge about drugs, drug targets, and topological methods" /><sentence text=" The goals were to build a system facilitating the study of adverse drug events, to make it easier to find possible explanations, and to group similar drug-drug interaction cases in the adverse drug reaction reports from the US Food and Drug Administration (FDA)" /><sentence text="" /><sentence text="We developed a system that analyses adverse drug reaction (ADR) cases reported by the FDA" /><sentence text=" The system contains four modules" /><sentence text=" First, we integrate drug and drug target databases that provide information related to adverse drug reactions" /><sentence text=" Second, we classify drug and drug targets according to anatomical therapeutic chemical classification (ATC) and drug target ontology (DTO)" /><sentence text=" Third, we build drug target networks based on drug and drug target databases" /><sentence text=" Finally, we apply topological analysis to reveal drug interaction complexity for each ADR case reported by the FDA" /><sentence text="" /><sentence text="We picked 1952 ADR cases from the years 2005-2006" /><sentence text=" Our dataset consisted of 1952 cases, of which 1471 cases involved ADR targets, 845 cases involved absorption, distribution, metabolism, and excretion (ADME) targets, and 507 cases involved some drugs acting on the same targets, namely, common targets (CTs)" /><sentence text=" We then investigated the cases involving ADR targets, ADME targets, and CTs using the ATC system and DTO" /><sentence text=" In the cases that led to death, the average number of common targets (NCTs) was 0" /><sentence text="879 and the average of average clustering coefficient (ACC) was 0" /><sentence text="067" /><sentence text=" In cases that did not lead to death, the average NCTs was 0" /><sentence text="551, and the average of ACC was 0" /><sentence text="039" /><sentence text="" /><sentence text="We implemented a system that can find possible explanations and cluster similar ADR cases reported by the FDA" /><sentence text=" We found that the average of ACC and the average NCTs in cases leading to death are higher than in cases not leading to death, suggesting that the interactions in cases leading to death are generally more complicated than in cases not leading to death" /><sentence text=" This indicates that our system can help not only in analysing ADRs in terms of drug-drug interactions but also by providing drug target assessments early in the drug discovery process" /><sentence text="" /></document>